Michael Allard

Michael Allard

Director, Renal Cell Carcinoma, Worldwide Oncology Commercial @ Bristol Myers Squibb

About Michael Allard

Michael Allard is the Director of Renal Cell Carcinoma, Worldwide Oncology Commercial at Bristol Myers Squibb in Princeton, New Jersey. He has extensive experience in oncology commercialization and has played key roles in product launches and regulatory approvals.

Title

Michael Allard is the Director of Renal Cell Carcinoma, Worldwide Oncology Commercial at Bristol Myers Squibb. He is based in Princeton, New Jersey, United States.

Current Role at Bristol Myers Squibb

Michael Allard currently serves as the Director of Renal Cell Carcinoma, Worldwide Oncology Commercial at Bristol Myers Squibb in Princeton, New Jersey. In this role, he has led the launch of a new oncology product that significantly improved patient outcomes in renal cell carcinoma. Additionally, he has developed and implemented a global marketing strategy for renal cell carcinoma treatments, resulting in increased market share.

Previous Roles at Bristol Myers Squibb

Before his current role, Michael Allard held several significant positions at Bristol Myers Squibb. He was the Associate Director, Worldwide Oncology Commercialization from 2019 to 2021 and Worldwide Congress Lead from 2017 to 2019, both based in Princeton, New Jersey. Earlier, he was part of the Product & Portfolio Strategy - Worldwide Commercialization team for five months in 2017 in Lawrenceville, New Jersey. As Commercial Lead - Hepatitis C in 2016, he operated in Montreal, Canada, and as Regional Business Manager from 2014 to 2016, he covered Ottawa and Atlantic Canada. He also served as Senior Product Manager for Abilify from 2012 to 2014 in Montreal, Canada.

Career at Novartis Pharma Canada

Michael Allard's career at Novartis Pharma Canada spanned several roles. From 2009 to 2012, he was the Brand Manager, followed by a brief period as Associate Brand Manager in 2009. Prior to these positions, he was a Medical Representative from 2006 to 2009. He initially joined Novartis as a Business Analyst, a role he held from 2004 to 2006.

Education and Expertise

Michael Allard holds a Bachelor of Business Administration in Marketing from HEC Montréal, where he studied from 2001 to 2004. He also achieved a Bachelor in Microbiology and Immunology from Université de Montréal, completed from 1998 to 2001. His academic background and professional experience have contributed to his expertise in oncology, commercialization strategies, and product management.

People similar to Michael Allard